Welcome to our dedicated page for Aptiv Plc SEC filings (Ticker: APTV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Aptiv PLC (NYSE: APTV) SEC filings page on Stock Titan provides access to the company’s U.S. regulatory disclosures, including Form 8-K current reports and other key documents filed with the Securities and Exchange Commission. As a Jersey-organized issuer with ordinary shares and multiple series of notes listed on the New York Stock Exchange, Aptiv uses these filings to report material events, financial results, capital markets transactions and significant corporate actions.
Recent Form 8-K filings show how Aptiv communicates quarterly performance and outlook, with reports tied to its financial results for periods ended June 30 and September 30. These filings reference press releases that detail revenue, operating income, non-GAAP measures such as Adjusted EBITDA and Adjusted Net Income, and guidance ranges, along with explanations of how management uses non-GAAP metrics to assess ongoing performance.
Other 8-Ks document governance and strategic developments. For example, Aptiv reported the appointment of Håkan Agnevall to its Board of Directors and disclosed the filing of a preliminary Form 10 by Cyprium Holdings Limited in connection with the intended separation of Aptiv’s Electrical Distribution Systems business into a new, independent publicly traded company, planned to be completed by March 31, 2026, subject to customary closing conditions. Additional filings list Aptiv’s various senior notes and fixed-to-fixed reset rate junior subordinated notes that are registered under Section 12(b) of the Exchange Act.
On Stock Titan, these SEC filings are complemented by AI-powered tools that help explain the structure and implications of documents such as 8-Ks, 10-Ks, 10-Qs and Form 4 insider transaction reports. Real-time updates from EDGAR, combined with AI-generated summaries, can assist users in quickly understanding Aptiv’s reported results, capital structure, governance changes and planned corporate transactions without reading every line of each filing.
Aptiv PLC has completed the previously announced spin-off of Versigent Limited, separating it into an independent company. The spin-off was executed through a pro rata distribution of all Versigent ordinary shares to Aptiv shareholders.
Each Aptiv shareholder of record on March 17, 2026 received one Versigent share for every three Aptiv ordinary shares held, with cash paid instead of fractional Versigent shares. The distribution occurred on April 1, 2026 at 12:01 a.m. Eastern time.
Versigent’s ordinary shares began trading on the New York Stock Exchange under the ticker symbol “VGNT” on April 1, 2026. A Separation and Distribution Agreement between Aptiv and Versigent governs the spin-off and ongoing relationships, and Aptiv plans to file required pro forma financial information by amendment.
Aptiv PLC ownership disclosure: The Vanguard Group amended its Schedule 13G/A to report 0 shares beneficially owned of Aptiv PLC common stock, representing 0% of the class.
The filing notes an internal realignment at The Vanguard Group, Inc. on January 12, 2026, after which certain subsidiaries report beneficial ownership separately in reliance on SEC Release No. 34-39538.
Aptiv PLC is conducting a cash tender offer of up to $1,371,000,000 to repurchase several series of outstanding senior notes through its subsidiary Aptiv Swiss Holdings Limited. The offer covers notes maturing between 2032 and 2054, with purchases prioritized by series and subject to individual caps.
The offer has been upsized from $1,350,000,000 after strong early participation. Early tenders include $447,590,000 of 3.250% notes due 2032 and $366,989,000 of 5.150% notes due 2034. Pricing is based on fixed spreads over specific U.S. Treasury yields, and early tenders receive a $30 per $1,000 premium.
The transaction is conditioned on completing the previously announced spin-off of Aptiv’s Electrical Distribution Systems business into Versigent and Aptiv receiving a special Versigent dividend of at least $1,700,000,000. Settlement is currently expected on April 7, 2026, with the tender offer scheduled to expire on April 3, 2026.
Aptiv PLC reported a leadership change in its Intelligent Systems business. On March 13, 2026, Executive Vice President and President, Intelligent Systems, Javed Khan informed the company he will resign effective March 30, 2026 to become chief executive officer of a software and AI company.
Following his departure, Khan will join Aptiv’s Technology Advisory Committee, maintaining a strategic relationship with the company. Chair and Chief Executive Officer Kevin Clark will assume the role of President, Intelligent Systems on an interim basis until a successor is named.
Aptiv PLC is asking shareholders to vote at its April 29, 2026 annual meeting in Shanghai on electing 11 directors, re‑appointing Ernst & Young LLP as auditor through the 2027 meeting, and approving executive compensation on an advisory basis.
The company highlights 2025 as a record year for revenue, adjusted EBITDA and adjusted EPS, supported by a resilient global supply chain and recognition from major customers. It reports approximately $27 billion in new business awards, cash flow from operations of $2.2 billion, operating income of $1.2 billion (adjusted operating income of $2.5 billion) and an operating income margin of 5.8% (12.1% on an adjusted basis).
Aptiv repurchased 22.8 million shares for $1.5 billion, deployed capital to repurchase $300 million of senior notes and repaid $250 million on its Term Loan A, while extending its credit agreement to March 2030. It plans to complete the tax‑free spin‑off of its Electrical Distribution Systems business as Versigent by April 1, 2026, following a 2024 reorganization that made Aptiv PLC the new publicly traded parent. The Board emphasizes strong governance, with 10 of 11 nominees independent, a lead independent director, fully independent key committees and active oversight of risk, sustainability and executive pay.
Aptiv PLC, a more than ten percent owner of Versigent Ltd, has filed an initial ownership report showing it holds 1,000 ordinary shares of Versigent, par value $0.01 per share, as of March 12, 2026. The shares are reported as held directly.
Aptiv PLC disclosed that its subsidiary Versigent Limited filed an amended Form 10 with the SEC as part of Aptiv’s plan to separate its Electrical Distribution Systems business into a new, independent publicly traded company.
The separation is expected to be structured as a tax-free spin-off to Aptiv shareholders. The company plans to complete the separation by April 1, 2026, subject to customary closing conditions.
Aptiv PLC is restructuring part of its debt as it prepares to spin off its Electrical Distribution Systems business into a new public company called Versigent. Its subsidiary Aptiv Swiss Holdings Limited has launched a cash tender offer to repurchase several series of outstanding senior notes for up to $1.35 billion in total consideration, excluding accrued interest.
The tender is conditioned on completing the Versigent spin-off and Aptiv receiving a special dividend of at least $1.7 billion from Versigent. Aptiv also plans to redeem the entire $401 million of its 4.650% Senior Notes due 2029 for cash, including a make-whole premium and accrued interest, with settlement expected on April 7, 2026 if those conditions are met. Versigent is expected to retain $400 million of cash on its balance sheet after paying the special dividend and related transaction costs.
Aptiv PLC plans to complete the spin-off of its Electrical Distribution Systems business into a new publicly traded company, Versigent. Aptiv’s board approved the separation and will distribute all Versigent ordinary shares to Aptiv shareholders as a pro rata dividend.
Aptiv shareholders of record at the close of trading on March 17, 2026 will receive one Versigent ordinary share for every three Aptiv ordinary shares, with cash paid instead of fractional shares. The distribution is expected before the U.S. market opens on April 1, 2026, subject to specified conditions. Versigent ordinary shares are expected to trade on the New York Stock Exchange under the ticker “VGNT”, including "when-issued" trading around March 27, 2026 and regular-way trading starting April 1, 2026. Shareholders are not required to take any action or pay consideration to receive the Versigent shares.